Data Challenge: Comparative Analysis of Surveillance Data and Infection Prevention and Control (IPC) Policies

Comparative Analysis of Surveillance Data and Infection Prevention and Control (IPC) Policies

Antimicrobial-resistant (AMR) pathogens are the most common cause of hospital-acquired infections. The spread of these pathogens to patients can occur through exposure to contaminated surfaces, medical devices, and the hands of healthcare staff. The source of the pathogen is usually infected patients or asymptomatic carriers. However, its spread is preventable through effective Infection Prevention and Control (IPC) policies, which promote proper screening and decolonization of carriers, and proper decontamination. Effective IPC involves the implementation of evidence-informed strategies to prevent and control infections in healthcare settings.
We hypothesize that the adoption of the IPC framework is influenced by a country’s level of economic development and its limited understanding of circulating pathogens. Understanding the distribution of multidrug-resistant organisms in both hospital and community settings is essential for the development of targeted interventions aimed at preventing and controlling AMR threats. Learning from countries that have successfully reduced healthcare-associated infections (HAI) through effective IPC policies is essential in developing evidence-based policy and AMR containment.
Data on pathogens causing HAI and CAI in different countries, coupled with IPC policies across different countries, can provide valuable insights into which strategies are effectively curbing the spread of AMR pathogens, particularly in hospital settings. Such data can help identify policy gaps, foster international collaboration for knowledge exchange, advocate for funding to support innovation in IPC practices, and ultimately inform more evidence-based decisions regarding the adoption and implementation of IPC policies. This approach is crucial in reducing the global burden of AMR. In this study, we aim to determine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and communities across various countries, compare current IPC policies, and highlight best practices that can be adapted to different healthcare settings.